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Notch receptors are large type 1 transmembrane gly-Summary
coproteins comprised of a characteristic series of struc-
tural domains, including extracellular iterated EGF re-Notch1 signaling drives T cell development at the ex-
peats and three LIN12/Notch repeats and intracellularpense of B cell development from a common precur-
RAM, ankyrin repeat, and PEST domains. Mammalssor, an effect that is dependent on a C-terminal Notch1
have four Notch receptors (Notch1–4), which show thetranscriptional activation domain. The function of Del-
greatest degree of homology within the ankyrin repeattex1, initially identified as a positive modulator of Notch
region and the greatest divergence in sequences lyingfunction in a genetic screen in Drosophila, is poorly
between the ankyrin repeats and the C-terminal PESTunderstood. We now demonstrate that, in contrast to
sequences. In Notch1, this structurally divergent regionNotch1, enforced expression of Deltex1 in hematopoi-
includes a strong transcriptional activation domainetic progenitors results in B cell development at the
(TAD) (Kurooka et al., 1998; Aster et al., 2000).expense of T cell development in fetal thymic organ
Although many details remain to be worked out, sev-culture and in vivo. Consistent with these effects, Del-
eral lines of investigation have converged recently upontex1 antagonizes Notch1 signaling in transcriptional
a consensus model for Notch signaling (for review, seereporter assays by inhibiting coactivator recruitment.
Mumm and Kopan, 2000). Binding of ligands of eitherThese data suggest that a balance of inductive Notch1
the Delta- or Serrate-like family to the extracellular do-signals and inhibitory signals mediated through Del-
main of Notch triggers at least two successive cleavage
tex1 and other modulators regulate T-B lineage com-
events that release the intracellular region (ICN) from its
mitment.
transmembrane tether. This permits ICN to translocate
to the nucleus, where it interacts with downstream tran-
Introduction scription factors. One major target for activated Notch
is CSL, also known as CBF1, Su(H), Lag-1, or RBP-J,
Several lines of experimental evidence indicate that a sequence-specific DNA binding transcription factor
Notch1 receptor signaling specifies the cell fate of com- that represses transcription in its basal state due to its
mon lymphoid progenitors. Notch1/ progenitor cells ability to bind corepressors, including N-CoR/SMRT and
derived from the bone marrow (BM) arrest at the early CIR (Jarriault et al., 1995; Kao et al., 1998; Hsieh et al.,
CD44CD25 pre-pro-T cell stage of T cell development 1999). Activated Notch1 (ICN1) relieves this repression
(Radtke et al., 1999). This block in T cell development in two ways: by binding CSL through RAM and ankyrin
is accompanied by the appearance of significant num- repeat domains, thereby displacing corepressors, and
bers of intrathymic sIgM B cells, which may arise from by recruiting coactivators such as PCAF and GCN5
a common lymphoid progenitor by a default pathway, through its C-terminal TAD (Kurooka et al., 1998; Aster
or from the homing of committed B cell progenitors to et al., 2000). Of note, the ability of Notch1 to drive T cell
the thymus. In contrast, the development of myeloid development is dependent on the TAD (Aster et al., 2000;
(Radtke et al., 1999) and intrathymic dendritic cells Aster and Pear, 2001), implying that recruitment of co-
(Radtke et al., 2000) is not impaired by Notch1 defi- activators is important for T cell specification by Notch1.
ciency, indicating that the nonredundant requirement The ability of ICN1 both to derepress CSL and to
recruit coactivators can be taken as evidence that Notchfor Notch1 in hematopoietic cells is restricted to an early
signaling needs to be “tuneable” and precisely regu-T cell precursor population positioned prior to the /
lated. This is supported further by the phenotypic effects branch point. In complementary studies, retroviral
induced by relatively minor changes in Notch dosage
during invertebrate development (Artavanis-Tsakonas5 Correspondence: wpear@mail.med.upenn.edu
et al., 1995) and by evidence that signaling is regulated at6 These authors contributed equally to this work.
multiple levels. Examples of negative regulators include7 Present address: TVW Telethon Institute for Child Health Research,
100 Roberts Road, Subiaco, Western Australia 6008, Australia. the Fringe glycosyl transferases (Bruckner et al., 2000;
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Moloney et al., 2000), which decrease the sensitivity of region of Deltex1. Thus, within lymphoid progenitors,
Deltex1 acts as a negative modulator of Notch1 signals.Notch to ligand-mediated activation, and Numb (Waka-
matsu et al., 1999), Disheveled (Axelrod et al., 1996),
Sel-10 (Hubbard et al., 1997), and Notchless (Royet et Results
al., 1998), which antagonize signals generated by intra-
cellular Notch. Alternatively, the nuclear factors SKIP Deltex1 Expression in Early Lymphoid Progenitors
(Zhou et al., 2000) and Mastermind (Petcherski and Kim- A previous report showed that Deltex1 is expressed
ble, 2000; Wu et al., 2000) bind the ankyrin repeats and in both immature CD4CD8 double-negative (DN) and
are proposed to enhance the activation of CSL. Super- mature CD4 and CD8 single-positive (SP) thymocytes
imposed on this complexity are positive (Luo et al., 1997) (Deftos et al., 2000). As a first step in dissecting the
and negative (Artavanis-Tsakonas et al., 1995) transcrip- function of Deltex1 in lymphopoiesis, we further charac-
tional feedback loops involving Notch and its ligands terized its expression in lymphoid progenitors. Subpop-
that add additional levels of control. ulations of developing B cells from the BM were purified
The Deltex genes belong to another distinct class of and subsequently assayed for Deltex1 expression by
Notch modifiers. Drosophila Deltex was initially identified RT-PCR analysis. Deltex1 is expressed in hematopoietic
as a positive modulator of Notch in a suppressor screen stem cells and during stages of B cell development
(Xu and Artavanis-Tsakonas, 1990; Gorman and Girton, (Figure 1A). Expression is highest in hematopoietic stem
1992). Genes of this type may have arisen relatively late cells (HSC) and pre-B cells (B220/CD43/HSAhigh/IgM)
in metazoan evolution, as no Deltex homolog has yet been and lowest in pro-B cells (B220/CD43/HSAintermediate/
identified in Caenorhabditis elegans. Mammals have three IgM). In contrast, Notch1 expression is low in HSCs
Deltex genes, of which Deltex1 is most closely related to and in B cells at all stages of their development, indicat-
Drosophila Deltex. Features shared by Drosophila Deltex ing that its expression is not correlated with that of
and Deltex1 include basic N-terminal regions that bind the Deltex1 (data not shown).
ankyrin repeats of Drosophila Notch (Diederich et al., 1994; To more precisely delineate patterns of Deltex1 ex-
Matsuno et al., 1995) and Notch1 (Matsuno et al., 1998), pression during early thymopoiesis, RT-PCR assays
respectively, and C-terminal RING finger domains (Bus- were performed on DN thymocyte subsets (Figure 1B).
seau et al., 1994; Kishi et al., 2001). It has been sug- Deltex1 is expressed at high levels in very early DN1,
gested that the Deltex1 gene is a transcriptional target downregulated in DN2 thymocytes, and then sharply
of activated Notch1 (Deftos et al., 2000), but its expres- upregulated in DN3 thymocytes, the stage during which
sion is widespread and may not be strictly Notch-depen- TCR rearrangement occurs (reviewed in Levelt and
dent (Matsuno et al., 1998). Eichmann, 1995). Notch1 expression is again not tightly
Several functions have been suggested for mamma- correlated with that of Deltex1, as Notch1 expression is
lian Deltex1. As a transcriptional target for ICN1, Deltex1 highest in DN2 thymocytes and then declines in DN3
can be envisioned to mediate or augment effects down- and DN4 cells. Although complex, the highly dynamic
stream of Notch1. For example, Deltex1, like ICN1, has pattern of Deltex1 expression is consistent with a role
been reported to inhibit the bHLH transcription factor in early B and T cell development.
E2A in transient expression assays (Matsuno et al., 1998;
Kishi et al., 2001). Other studies using cultured cells Deltex1 Inhibits T Cell Development and Induces
have suggested that Deltex1 inhibits MAPK, potentially Intrathymic B Cell Development
through a direct interaction with grb2 (Ordentlich et al., To investigate the effect of Deltex1 on hematopoietic
1998). Finally, while genetic studies have suggested that development, mice were reconstituted with BM-derived
Drosophila Deltex is a positive regulator of Notch, hu- hematopoietic progenitors transduced ex vivo by retro-
man Deltex1 opposes the effect of Notch1 on neurite viruses that coexpress Deltex1 and GFP from a bicis-
outgrowth from neurons (Sestan et al., 1999). tronic transcript (Figure 2A). We previously used this
Based on the positive effects of Deltex on Notch func- assay to show that enforced Notch1 signaling drives
tion in Drosophila and data suggesting that Deltex1 is T cell commitment at the expense of B cell development
a transcriptional target of Notch1, we hypothesized that from a common lymphoid progenitor (Pui et al., 1999).
Deltex1 would act as a positive mediator of signals gov- As compared to control mice reconstituted with BM cells
erning T cell specification. To test this hypothesis, we expressing GFP alone, mice reconstituted with Deltex1-
transduced BM and fetal liver hematopoietic progenitor transduced BM cells showed a marked decrease in the
cells with retroviruses coexpressing Deltex1 and GFP. percentage of GFP mature T cells in the peripheral
Unexpectedly, recipients of transplanted BM cells blood and spleen (Figure 2B and data not shown). In
showed a marked decline in GFP T lineage cells in contrast, Deltex1/GFP and control GFP mice showed
the thymus and peripheral blood accompanied by an similar percentages of GFP mature peripheral B cells
increase in intrathymic GFP B cells. Further, Deltex1- and BM B cell progenitor subsets (defined as described
transduced fetal liver hematopoietic stem cells gave rise in Hardy et al., 1991; Li et al., 1996; Allman et al., 1999)
to oligoclonal GFP B cells and very few T lineage cells and myeloid progenitors (data not shown). Further, while
in fetal thymic organ cultures, as compared to control the thymuses of GFP control mice contained between
stem cells expressing GFP alone. In transactivation 17% and 73% GFP cells at 45 days after BM reconstitu-
assays, Deltex1 did not repress E2A but did specifically tion, the thymuses of mice receiving Deltex1-transduced
inhibit the function of the transcriptional activation do- BM cells contained very few GFP cells (1%) (Figure
main of ICN1, an effect that required the ankyrin repeats 3A). In control thymuses, GFP and GFP cell popula-
tions showed very similar distributions of developingof ICN1 and the amino-terminal ankyrin repeat binding
Deltex1 in Lymphoid Commitment
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Figure 1. Deltex1 Is Expressed in Developing B and T Cells
(A) Deltex1 expression in B cell development. Total RNAs prepared from purified hematopoietic stem cells (HSC), common lymphoid progenitors
(CLP), and developing B cells (Hardy Fractions A1-F) were used to synthesize cDNA. Fraction A1/A2 contains pre-pro-B cells, fraction B/C
contains pro-B cells and early pre-B cells, fraction D contains late pre-B cells, and fractions E/F contains immature/mature B cells, respectively.
After normalization based on HPRT expression, cDNAs were amplified using murine Deltex1 (Dtx-1) primers and analyzed on Southern blots
hybridized to a murine Deltex1-specific 32P-labeled oligonucleotide probe. 70Z cell cDNA, no input cDNA, and genomic DNA were used as
negative controls, whereas cDNA prepared from ICT22 cells, a Notch-expressing T cell tumor line (Pear et al., 1996), served as a positive
control. The sorting parameters for all fractions are described in Experimental Procedures.
(B) Deltex1 and Notch1 expression in early T cell development. Total RNAs prepared from purified thymocytes DN1-DN4 fractions, according
to the parameters described in Experimental Procedures, were used to synthesize cDNA. After normalization based on HPRT expression,
cDNAs were amplified using murine Deltex1 or murine Notch1 primers and analyzed on ethidium bromide-stained agarose gels. 70Z cell
cDNA, no input cDNA, and genomic DNA were used as negative controls, whereas cDNA prepared from ICT22 cells, a Notch-expressing
T cell tumor line (Pear et al., 1996), served as a positive control. Fewer cells were obtained from the DN1 population, as indicated by the
HPRT amplifications at 25, 30, and 35 cycles.
thymocytes, whereas in Deltex1 thymuses, an increased chain rearrangements (data not shown). The GFP frac-
tions of FTOCs receiving Deltex1-transduced fetal liverproportion of CD4CD8 cells was observed in the small
GFP fraction (Figure 3A). Additional immunophenotyp- cells showed normal T cell development (Figure 4A),
consistent with the effects of Deltex1 being cell autono-ing revealed that this population was enriched for
B220IgM B cells, which were at least 4-fold more mous. Additional statistical analyses revealed highly sig-
nificant differences in the proportion of CD48 cellsprevalent in Deltex1/GFP mice than in GFP control mice
(Figure 3B). The GFP fractions of mice receiving Del- (49.4%  1.6% versus 7.1%  1.1%, p 	 0.0001) and
CD19 cells (0.3%  0.05% versus 35.7%  6.6%, p 	tex1-transduced BM cells were highly similar to those
of control animals (Figure 3A), consistent with Deltex1 0.005) in the GFPpopulations of control (n
 6 indepen-
dent FTOC) and Deltex1-transduced FTOCs (n 
 13having a cell autonomous effect. Statistical analysis
demonstrated significant differences in the generation independent FTOC), respectively.
Together, these in vivo and organ culture studies showof CD48 cells from control and Deltex1-transduced
thymuses (77.6% 4.5% versus 51.2% 6.9%, respec- that enforced expression of Deltex1 promotes Bcell lymph-
opoiesis at the expense of T cell development. This phe-tively; p	 0.05) and B220 (0.9% 0.4% versus 25.3%
8.7%, respectively, p	 0.05, n
 9 MigR1 and 6 Deltex1 notype is the opposite of that produced by constitutively
active forms of Notch1 (Pui et al., 1999) and closelythymuses). Hence, these results suggested that en-
forced expression of Deltex1 inhibits T cell development resembles that produced by Notch1 deficiency (Radtke
et al., 1999) or Fringe-mediated inhibition of Notch sig-and promotes intrathymic B cell development.
naling (Koch et al., 2001). Based on these observations,
we pursued the hypothesis that Deltex1 was acting asDeltex1 Expression Redirects Differentiation to a B
an inhibitor of some aspect of Notch1 signaling.Cell Fate in Mouse Fetal Thymic Organ Culture
The effects of Deltex1 on lymphopoiesis were further
examined in a fetal thymic organ culture (FTOC) assay. Deltex1 Inhibits Transcriptional Activation by ICN1
A series of cell culture assays were used to investigateThese experiments used fetal liver hematopoietic pro-
genitors, which are superior to BM-derived hematopoi- the ability of Deltex1 to inhibit transactivation by consti-
tutively active Notch1 (ICN1). Deltex1 partially inhibitedetic progenitors in repopulation of FTOC following ret-
roviral transduction (Izon et al., 2001a). Strikingly, the transactivation of a CSL-dependent luciferase re-
porter by ICN1 in human U2OS cells (Figure 5A) andDeltex1/GFP-expressing cells did not produce T cells
in FTOC (Figure 4A) but gave rise to both early murine NIH 3T3 cells (data not shown), while having no
effect on the basal activity of the reporter gene. Similar(CD19IgM) and more mature (CD19IgM) B cells,
which were elevated10-fold as compared to the GFP experiments undertaken in both B and T cell lines also
demonstrated a dose-dependent inhibition of ICN1 bypopulation in control FTOCs (Figure 4B). This Deltex1-
induced B cell population harbored oligoclonal  heavy Deltex1 (Figure 5B), suggesting that this is a general
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Figure 2. Deltex1 Expression Reduces Peripheral Blood T Cells without Affecting B Cells
(A) Schematic of MigR1 control retroviral vector and Mig Deltex1 retroviral vector. The domain structure of Deltex1 is shown, and specific
amino acid residues are indicated. Abbreviations are as follows: LTR, long terminal repeat derived from murine stem cell virus; N interaction,
Notch interaction domain; SH3 BD, SH3 binding domain; IRES, internal ribosomal entry site; and GFP, green fluorescent protein.
(B) GFP versus TCR FACS contour plots of MigRI (control) and Deltex1 peripheral blood. Lethally irradiated C57Bl/6 mice were reconstituted
with BM cells transduced with empty MigR1 or Mig Deltex1. On day 35 posttransplantation, peripheral blood was analyzed by flow cytometry.
The results are representative of nine MigR1 and six Deltex1 mice.
(C) GFP-gated CD19 versus IgM FACS contour plots of MigRI (control) and Deltex1 peripheral blood. The GFP histograms are shown on the
left. The y axis of each histogram represents cell number. The peripheral blood samples are the same as in (B).
activity and not strictly dependent on cell type. Addi- an unrelated transactivating protein also implicated in
Notch1 signaling (Wu et al., 2000). In other experiments,tional experiments revealed that Deltex1 did not inhibit
the activation of CSL by ICN1(TAD-P) (Figure 5A), Deltex1 also markedly abrogated the transactivation ac-
tivity of GAL4-ICN1 in lymphoid cell lines (data notwhich lacks the ability to recruit coactivators due to
deletion of the TAD (Kurooka et al., 1998; Aster et al., shown). The amino terminus of Deltex1 (aa 1–242), which
contains a domain that directly interacts with the Notch12000). Because ICN1(TAD-P) retains the ability to dis-
place corepressors (Hsieh et al., 1996, 1999), these cor- ankyrin repeats (Matsuno et al., 1998), was sufficient to
inhibit transactivation by GAL4-ICN1 but did not inhibitrelates suggested that Deltex1 specifically antagonized
the portion of CSL activation that stems from coactivator GAL4-ICN1ANK, a polypeptide lacking the ankyrin re-
peats (Figure 5D). Taken together, these data suggestedrecruitment.
This possibility was further investigated by studying that Deltex1 inhibits recruitment of coactivators to the
C-terminal TAD indirectly through an interaction requir-the effects of Deltex1 on the transactivation of a GAL4-
luciferase reporter gene by GAL4-ICN1 fusion proteins. ing the ankyrin repeats of Notch1.
Deltex1 possesses a C-terminal RING finger, a motifSmall doses of Deltex1 plasmid completely abrogated
transactivation by GAL4-ICN1 (Figure 5C), while having that is commonly present in ubiquitin ligases (Jackson
et al., 2000), suggesting that it might inhibit Notch1 byminimal effects on GAL4-MAML-1 (mastermind-like-1),
Deltex1 in Lymphoid Commitment
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Figure 3. Deltex1 Inhibits T Cell Development and Induces Intrathymic B Cell Development
(A) GFP-gated CD4 versus CD8 FACS contour plots of MigRI (control) and Deltex1 thymus. The GFP histograms are shown on the left. The
y axis of each histogram represents cell number.
(B) GFP-gated B220 versus IgM FACS contour plots of MigRI (control) and Deltex1 thymus. The thymus samples are from an independent
set of mice from those in Figure 3A. The results are representative of nine control and six Deltex1 mice.
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Figure 4. Deltex1 Expression Redirects Differentiation to the B Cell Fate in Mouse Fetal Thymic Organ Culture
(A) FACS contour plots and histograms of fetal thymic organ cultures reconstituted with fetal liver cells transduced with MigR1 (control) or
Mig Deltex1 and analyzed using GFP and CD4 and CD8 antibodies. Irradiated d15 fetal thymic lobes were reconstituted with fetal liver cells
expressing either GFP or Deltex1 and cultured for 16 days. The GFP histograms are shown on the left. The y axis of each histogram represents
cell number.
Deltex1 in Lymphoid Commitment
237
targeting it for degradation. However, coexpression of data implicating Notch1 in T cell specification (Radtke
et al., 1999; Koch et al., 2001), these findings provideDeltex1 did not affect the steady-state levels of ICN1 pro-
tein (Figure 5E), and pulse-chase experiments showed no further support for a model in which strong Notch1 sig-
nals are necessary for induction of T cell developmentdecrease in ICN1 half-life when Deltex1 was overex-
pressed (J.C.A., unpublished data), suggesting that from lymphoid progenitors (Figure 7). A requirement for
high-intensity signaling is in line with Notch1 being mostother mechanisms are operative.
highly expressed in developing thymus (Ellisen et al.,
1991; Hasserjian et al., 1996) and may explain why partialDeltex1 Can Potentiate E2A Activity
One mechanism by which Notch1 may promote T cell inhibition of Notch1 signaling by Deltex1 is sufficient to
block T cell specification.development is through the inhibition of E2A, a tran-
scription factor required for the earliest stages of B cell Further work will be needed to determine whether
Deltex1 inhibits all or only a subset of Notch1 functions.development (Bain et al., 1994, 1997). It has been re-
ported that Deltex1 inhibits E2A activity in reporter The latter possibility is suggested by our data showing
that Deltex1 is a partial antagonist, as it is a potentassays (Ordentlich et al., 1998). However, the promotion
of B cell development by Deltex1 suggested that it was inhibitor of coactivator recruitment but does not appear
to influence displacement of corepressors from CSL byunlikely to be a physiologic inhibitor of E2A, and we
therefore reexamined its effects on E2A. At relatively Notch1. As a result, enforced expression of Deltex1 may
only inhibit that subset of Notch1-dependent pheno-low input doses of Deltex1 plasmid, mild to moderate
(2- to 10-fold) potentiation of E2A activity was observed types that require strong signals. It will also be interest-
ing to study whether Deltex1 affects Notch1-mediatedin 293T cells (Figure 6A). Similar doses of Deltex1 plas-
mid had little effect on E2A activity in NIH 3T3 cells CSL-independent signals (such as the inhibition of myo-
genesis; see Shawber et al., 1996), or whether it has(Figure 6B), whereas ICN1 antagonized E2A, as reported
previously (Ordentlich et al., 1998). Furthermore, tran- effects completely independent of Notch, which have
been predicted based on its ability to inhibit severalsient expression of Deltex1 in B and T cell lines also
potentiated the activity of E2A (Figure 6C), indicating bHLH transcription factors in transient expression
assays (Ordentlich et al., 1998; Kishi et al., 2001).that this appears to be a general effect of Deltex1. Impor-
tantly, in all cases E2A was either unaffected or stimu- Our finding that Deltex1 is a negative modulator of
Notch1 activity is surprising, as genetic studies havelated by input doses of Deltex1 sufficient to cause inhibi-
tion of Notch1. been interpreted as showing Drosophila Deltex to have
positive effects on Notch signals. However, our current
results were foreshadowed by the ability of Deltex1 toDiscussion
oppose the effects of Notch1 on dendritic outgrowth
from human neurons (Sestan et al., 1999). The explana-In this report, we show that enforced Deltex1 expression
inhibits T cell development from both adult BM and tion for this functional divergence during evolution is
unclear, but several points may be relevant. Deltexfetal liver hematopoietic progenitors, while enhancing
ectopic B cell development within the thymic microenvi- genes seem to have appeared relatively late during the
evolution of the Notch signaling pathway, as no homologronment in a cell-autonomous fashion. These effects
resemble those produced by Notch1 deficiency (Radtke has been identified in C. elegans, suggesting that they
have been superimposed on an established pathwayet al., 1999) or enforced expression of a well-character-
ized Notch signaling antagonist, lunatic fringe (Koch et to provide additional regulatory control. In support of
Deltex being a modifier rather than an integral compo-al., 2001). In support of Deltex1 being a bona fide Notch1
inhibitor, we find that Deltex1 inhibits the recruitment of nent of the Notch signaling pathway, Deltex loss-of-
function in Drosophila produces phenotypes distincttranscription coactivators by Notch1 in transient expres-
sion assays. This activity is one likely basis for Deltex1’s from those caused by Notch loss-of-function (Gorman
and Girton, 1992). Perhaps the use of Deltex1 as a nega-stimulation of B cell development in the thymus, which
may occur through a default pathway when T cell devel- tive modifier reflects a need for tighter regulation of
Notch activity in higher animals. Because of the potentialopment is inhibited. However, we noted that E2A activity
was augmented in some contexts by Deltex1, sug- for complex interactions with Notch signaling, we also
cannot exclude the possibility of agonistic interactionsgesting that it could also promote B cell development.
Taken together, these findings provide new insight into between Notch and Deltex1 in cellular contexts other
than early lymphoid development.the function of Deltex1 and raise a number of issues
pertaining to its normal role in lymphoid development. Resolution of these uncertainties awaits the elucida-
tion of how Deltex polypeptides function. Yeast two-The ability of Deltex1 to antagonize the function of
the Notch1 transcriptional activation domain provides hybrid analyses have shown that the N-terminal portion
of Deltex1 can associate with the ankyrin repeats ofan attractive explanation for the observed effects of
enforced Deltex1 expression, as the transcriptional acti- Notch1 (Matsuno et al., 1998), which could in turn pre-
vent the association of positive regulators, such asvation domain of Notch1 contributes to its ability to drive
T cell specification (Aster et al., 2000). Along with other MAML-1 (Wu et al., 2000) and SKIP (Zhou et al., 2000).
(B) FACS contour plots and histograms of fetal thymic organ cultures reconstituted with fetal liver cells transduced with MigR1 (control) or
Mig Deltex1 and analyzed using GFP and CD19 and IgM antibodies. The FTOC samples are the same as in (A). The results are representative
of 6 independent MigR1 and 13 independent Dtx1 FTOC experiments.
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Figure 5. Deltex1 Inhibits Notch1 Transactivation
(A and B) Deltex1 partially inhibits Notch1 activation of CSL-dependent reporters.
(A) U2OS cells in 24-well dishes were cotransfected in triplicate with the indicated amounts of pcDNA3 plasmids (Invitrogen) encoding portions
of the intracellular domain of human Notch1 (ICN1) or human Deltex1 (Dtx-1), 500 ng of a CSL firefly luciferase reporter plasmid (Hsieh et al.,
1997), and 10 ng of an internal Renilla luciferase control plasmid, pRL-TK (Promega). The fold stimulation represents the ratio of the normalized
firefly luciferase activities to that of an empty plasmid control. Firefly and Renilla luciferase activities were determined using a dual luciferase
assay (Promega) in whole cell lysates prepared 48 hr after transfection or electroporation. The inset is a schematic showing the structure of
ICN1 polypeptides. Abbreviations are as follows: ANK, ankyrin repeat; TAD, transcriptional activation domain; and P, PEST sequence. The
data represent results from three independent experiments.
(B) BJAB or Jurkat cells (107 cells/treatment) were coelectroporated with the indicated amounts of pcDNA3 expression plasmids, 10 g of
a CSL firefly luciferase reporter, and 1.25 g of pRL-TK. Normalized firefly luciferase activities were determined and expressed as in (A). The
inhibitory effects of Deltex1 were studied in three independent experiments. A representative set of results from one experiment is shown.
(C) U2OS cells in 24-well dishes were cotransfected in triplicate with 10 ng of pM plasmids (Clontech) encoding the DNA binding domain of
GAL4 fused to human ICN1 or MAML-1, pcDNA3 plasmids encoding human Deltex1 (Dtx-1), 500 ng of GAL4-firefly luciferase reporter, and
10 ng of an internal Renilla luciferase control plasmid. Normalized firefly luciferase activities were determined and expressed as in (A). The
data represent results from three independent experiments.
(D) U2OS cells were cotransfected with the same mixture of GAL-4 firefly luciferase and Renilla luciferase reporters, 10 ng of pM plasmids
encoding the DNA binding domain of GAL4 fused to human ICN1 or ICN1ANK, and pCMV2 plasmid encoding amino acids 1–242 of human
Deltex1 (Dtx-1). Relative normalized firefly luciferase activities were determined as in (A). The data represent results from three independent
experiments. The inset is a cartoon showing the structure of GAL4-ICN1 and Deltex1-242 polypeptides. Abbreviations are as follows: NID,
notch interaction domain; RF, RING finger. Normalized firefly luciferase activities were determined and expressed as in (A).
(E) 293A cells in 6-well dishes were cotransfected with the indicated amounts of pcDNA3 plasmids encoding forms of ICN1 or Deltex1 with
three iterated C-terminal myc epitopes, as well as 50 ng of pRL-TK internal control. After 48 hr, whole cell extracts were prepared with ice-
cold 50 mM Tris (pH 8.0) containing 150 mM NaCl, 5 mM EDTA, and 1% NP-40. Renilla luciferase activity, determined using a commercially
available substrate (Promega) and a TD20 luminometer, was used to normalize the loading of a discontinuous 8% SDS-polyacrylamide gel.
A Western blot was prepared and stained with mouse anti-myc (clone 9E10) using a chemiluminescent detection method (Pierce).
This N-terminal domain, which includes two WWE motifs protein interaction domain that competes directly or indi-
rectly with ICN1 for transcriptional coactivators.(Aravind, 2001), is sufficient to prevent recruitment of
coactivators by Notch1, suggesting that it is critical for The role of Deltex1 during normal hematolymphoid
differentiation is unknown, but our data suggest severalDeltex1 inhibition. Although Deltex1 has a C-terminal
RING finger, a domain implicated in the function of ubi- possibilities. One is to negatively regulate the strength
and duration of Notch1 signals during thymocyte devel-quitin ligases, Deltex1 does not appear to augment ICN1
degradation, and indeed, the RING finger domain is not opment. Progression from the DN1 to the DN3 stage
of thymocyte differentiation is marked by a transientrequired for ICN1 inhibition. These observations suggest
that the N-terminal portion of Deltex1 contains a protein: increase in Notch1 expression in DN2 cells. In contrast,
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Figure 6. Deltex1 Can Potentiate E2A Trans-
activation
(A) 293T cells were cotransfected in triplicate
with the indicated plasmids, 150 ng of an
E2A-sensitive firefly luciferase reporter (Car-
ter et al., 1997), and 10 ng of an internal Renilla
luciferase control plasmid. Relative normalized
firefly luciferase activities in whole cell extracts
prepared 48 hr posttransfection were mea-
sured and normalized as in Figure 5A.
(B) NIH 3T3 cells were cotransfected with the
indicated plasmids (cloned into MigR1), 50 ng
of the E2A-sensitive firefly luciferase reporter
(Carter et al., 1997), and 50 ng of the -galac-
tosidase expression plasmid, pON405. Lucif-
erase activities in whole cell extracts pre-
pared 46 hr posttransfection were measured
as above and normalized using the corre-
sponding -galactosidase activity. The data
represent results from three independent ex-
periments.
(C) BJAB or Jurkat cells (107 cells/treat-
ment) were coelectroporated with the indi-
cated amounts of MigRI expression plas-
mids, 10 g of E2A firefly luciferase reporter,
and 1.25 g of pRL-TK. Relative normalized
firefly luciferase activities in whole cell ex-
tracts prepared 48 hr posttransfection were
measured and normalized as in Figure 5A.
The stimulatory effects of Deltex1 were stud-
ied in three independent experiments. A rep-
resentative set of results from one experiment
is shown.
Deltex1 expression falls in DN2 cells and then rebounds ligands on developing thymocytes and thymic stromal
cells. The need for a strong Notch1 signal for progres-to high levels in DN3 cells. Together with the observation
that Notch1-deficient thymocytes arrest at the DN1 stage sion to the DN2 stage is supported by the observation
that maturation is blocked at the DN1 stage in Notch1-of maturation, these patterns of expression suggest that
the thymic microenvironment promotes commitment to deficient thymoctyes (Radtke et al., 1999; Koch et al.,
2001). As maturation proceeds, upregulation of Deltex1T cell fate by initially adjusting the balance of Notch1
signaling and Deltex1 antagonism in DN2 cells in favor in DN3 cells may serve to limit the strength and duration
of normal Notch1 signaling to around the time of theof Notch1. This may be achieved both by upregulation
of Notch1 expression and the expression of activating DN2 to DN3 transition. The potential importance of this
Figure 7. Mechanism of Deltex1 Inhibition of Notch1
Notch1 activates CSL by displacing corepressors and recruiting coactivators. Deltex1 specifically prevents the recruitment of coactivators
and limits CSL activation below the threshold needed for induction of T cell fate. Deltex1 may also actively promote B cell fate in common
lymphoid progenitors through potentiation of E2A in addition to inhibition of Notch1 (data not shown).
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Deltex1 activity is emphasized by the effects of enforced mitment, growth, and survival within an ectopic environ-
Notch1 signaling, arrested development of CD4CD8 ment (in this case, the thymus). Better understanding of
thymocytes (Izon et al., 2001a), and rapid appearance the events that initiate and sustain E2A expression, as
of lethal T cell leukemias (Pear et al., 1996; Aster et al., well as the mechanism of Deltex1 interaction with E2A,
2000). Furthermore, inducible Notch1 knockout mice, in will be needed to clarify the importance of Deltex1 sig-
which Notch1 is inactivated late in the DN3 stage of nals in B lymphopoiesis.
thymocyte development, show no defects in T cell devel- Because Notch1 is involved in many cell fate decisions
opment; a finding consistent with the hypothesis that and Deltex1 and related polypeptides are widely ex-
Notch1 activity is rate limiting during a narrow window pressed (Kishi et al., 2001), the interplay of Notch1 and
of early T cell development (Wolfer et al., 2001). It is also Deltex1 is likely to influence the development of many
possible that downregulation in DN3 cells acts in some nonlymphoid tissues. These interactions may prove to
way to reset Notch signaling, facilitating its reuse during be highly complex, given the possible upregulation of
subsequent T lineage cell fate decisions. Deltex1 expression by Notch1 (Deftos et al., 1998) as
In contrast to T cell progenitors, Notch1 is expressed well as possible Notch1-independent Deltex1 functions
at low to undetectable levels in B cell progenitors (S.B., (Matsuno et al., 1998; Ordentlich et al., 1998; Kishi et
C.R., and W.S.P., unpublished data), whereas Deltex1 al., 2001). Further work will be needed to delineate the
is expressed in both early and late B cell progenitors. breadth and overall importance of Deltex1 function in
The unopposed expression of Deltex1 indicates that its vertebrates.
expression is not strictly dependent on Notch1. Because
strong Notch1 signals inhibit all stages of B cell differen- Experimental Procedures
tiation (Pui et al., 1999), Deltex1 may cooperate with
Plasmids and Expression Constructsother factors to ensure that Notch signals in B cell pro-
Expression constructs for human Notch1 (Aster et al., 2000) andgenitors are restricted to levels conducive to B cell de-
human MAML1 (Wu et al., 2000) have been described previously. Avelopment. In this context, it is important to note that
full-length human Deltex1 cDNA (the kind gift of Dr. Spyros Arta-
the outcome of Notch signaling is dependent on the net vanis-Tsakonas) was used as a template in a PCR to create a cDNA
inputs of both positive regulators, such as Mastermind encoding amino acids 1–242 Deltex1, which was ligated into the
and SKIP, and negative regulators, such as CIR, Fringe, plasmid pCMV2. A full-length murine Deltex1 cDNA, amplified by
PCR using the sense primer 5-AAAAGATCTCAGGCGGCAGCGGCNumb, and Deltex (reviewed in Izon et al., 2002). Thus,
CATGTC-3 and the antisense primer 5-AAGGGAATTCGGGCAACa complete understanding of the role of Deltex in Notch-
TCAGGCCTCAG-3, was ligated into the retroviral shuttle vectorregulated cell fate decisions will require a comprehen-
MigR1 (Pui et al., 1999). The identities of cDNAs synthesized usingsive analysis of Notch signaling in lymphoid progenitors,
the PCR were confirmed by DNA sequencing.
as well as the identification of relevant Notch-dependent
transcriptional targets in these cells. Nevertheless, our
Flow Cytometry and Cell Sorting
data, obtained from in vivo, organ culture, and biochemi- Cell suspensions from mouse BM, thymus, or fetal liver-reconstitu-
cal studies, are all consistent with a role for Deltex1 ted fetal thymus were washed in phosphate-buffered saline (PBS)
in inhibiting Notch1 signaling and redirecting lymphoid with 1% fetal calf serum (FCS) and 0.01% NaN3 (FACS buffer). Fc
receptors were blocked by preincubation with 30 l hybridoma su-progenitors to the B cell fate.
pernatant 2.4G2 (anti-FcR clone). Cells were then stained with ap-In addition to its role as a Notch inhibitor, we also
propriately diluted fluorochrome/biotin-conjugated 1 antibodies forobserved that Deltex1 potentiated the activity of E2A
20 min at 4C and washed in 200 l FACS buffer. Staining within some transient expression assays. This result was
streptavidin 2 reagents was performed in an identical fashion. La-
unexpected, as several previous reports showed that beled cells were resuspended in 400 l, acquired on a Becton Dick-
Deltex1 inhibited E2A in cell culture assays (Ordentlich inson FACScalibur, and analyzed using FlowJo software (Treestar,
et al., 1998; Kishi et al., 2001). However, E2A function Inc., San Carlos, CA). Routinely, 3  104 to 1  105 viable cells were
analyzed.is essential for B lymphopoiesis (Bain et al., 1994), yet
HSCs and CLPs were sorted based on Lin/IL-7R/c-kit/Sca-we observed no apparent effect of enforced Deltex1 on
1 and Lin/IL-7R/AA4.1/Sca-1low surface phenotypes, respec-B cell development in the bone marrow or spleen, and
tively (Kondo et al., 1997; Izon et al., 2001b), from C57Bl/6 bonesaw enhanced intrathymic B cell development, all of marrow cells. The A1/A2 B cell fractions were prepared from bone
which are incompatible with Deltex1 being a potent in- marrow cells that were stained with FITC-anti-B220, PE-anti-AA4.1,
hibitor of E2A. Possible explanations for the differences and biotin-anti-CD24/HSA, revealed with APC-Cy7-streptavidin,
in reporter gene assays include the use of larger and identified within the HSA/AA4.1/B220 gate. All other B cell
fractions were prepared from BM cells that were stained with FITC-amounts of plasmids, different promoters for expres-
anti-CD43, PE-anti-IgM, biotin-anti-CD24/HSA, and APC-anti-B220sion, and much higher ratios of Deltex1 to E2A in the
(CD45R), using the following gates: B220/CD43/HSAintermediate/IgMprevious studies than our own.
(fraction B/C); B220/CD43/HSAhigh/IgM (fraction D); B220/
Conceivably, potentiation of E2A by Deltex1 could CD43/HSAhigh/IgM (fraction E); and B220/CD43/HSAlow/IgM
allow Deltex1 to have a role in promoting B cell develop- (fraction F) (Hardy et al., 1991; Li et al., 1996; Allman et al., 1999).
ment from common lymphoid progenitors, which do ex- T cell progenitors were prepared from thymocytes that were stained
press Deltex1. However, the fraction of cells expressing with APC-anti-CD44 (Pharmingen, San Diego, CA), PE-anti-CD25
(Caltag, Burlingame, CA) biotin-anti-CD3, CD4, CD8, CD19, and anti-transduced Deltex1 in fetal thymic organ cultures was
Mac-1 (“Lin” cocktail, all from Pharmingen, San Diego, CA), usingtypically 10%–20% of GFP-only controls. In contrast, in
the following gates: Lin/CD44/CD25 (DN1), Lin/CD44/CD25bone marrow reconstitution experiments, the proportion
(DN2), Lin/CD44/CD25 (DN3), and Lin/CD44/CD25 (DN4)
of marrow-derived B cells expressing Deltex1 did not (Godfrey et al., 1994). Biotinylated antibodies were revealed with
differ from the GFP controls. These differences suggest streptavidin Cy5 (Pharmingen, San Diego, CA).
that enforced expression of Deltex1 is not sufficient to Additional antibodies that were used in these studies were anti-
TCR (H57)-phycoerythrin (PE), anti-Gr-1 (RB6-8C5)-PE, anti-CD4support optimal levels of signals needed for B cell com-
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(RM4-5)-allphycocyanin (APC), anti-IgM (331.31) PE, anti-CD8 bio- 24 hr, the reconstituted fetal thymic lobes were placed on 0.8 m
polycarbonate membranes (Isopore, Millipore, Ireland).tin, anti-CD19 biotin, and anti-CD11b/Mac-1 (M1/70) biotin and re-
vealed with Streptavidin-Cy5 or Streptavidin RED 670 (all from Phar-
mingen, San Diego, CA). Statistical analyses were performed using Reporter Assays
Expression plasmids encoding polypeptides of interest (see Figuresthe Student’s t test.
For experiments involving cell sorting, each cell population was 5 and 6) were transfected into human 293T or U2OS cells or into
murine NIH 3T3 cells with lipofectamine (GIBCO-BRL), or were elec-purified on a 10 parameter MoFlo cell sorter (Cytomation, Fort Col-
lins, CO) equipped with Summit software and three lasers including troporated into BJAB or Jurkat cells using a BioRad Electroporator
with Capacitance Extender Plus. To assay various Notch1 or E2Aan I-90C argon laser tuned to 488 nm and an I-70C Spectrum argon/
krypton laser (both from Coherent, Santa Clara, CA) tuned to 647 activities, expression plasmids were mixed with either a CSL-depen-
dent firefly luciferase gene reporter (Hsieh et al., 1997), a GAL4 nm for excitation of APC and its derivatives.
5 firefly luciferase reporter (Aster et al., 2000), or an E2A firefly
luciferase reporter (Carter et al., 1997). In most assays, the plasmidRT-PCR
mixtures also contained an internal control pRL-TK plasmid, whichTotal RNA, extracted from 1  105 cells using TRIZOL Reagent
drives the expression of a Renilla luciferase gene from the thymidine(GIBCO-BRL, Gaithersburg, MD) according to the manufacturer’s
kinase promoter. Normalized luciferase activities were determinedinstructions, was resuspended in 20 l water. For cDNA synthesis,
in triplicate 48 hr posttransfection in whole cell lysates using a4 l of RNA was heated to 70C for 5 min in a total volume of 20 l
Dual Luciferase Kit (Promega) and a Turner Systems luminometerH20 and then rapidly cooled to 4C. M-MLV RT 5 buffer
configured for dual assays. In assays of E2A activity in NIH 3T3 cells,(Promega, Madison, WI), dNTPs (0.5 mM), random hexanucleotide
cells were cotransfected with the E2A-sensitive firefly luciferaseprimers (1 g, Boehringer Mannheim), and M-MLV reverse tran-
reporter and a -galactosidase internal control plasmid, pON405.scriptase (200 U, Promega) were then added. The reaction mixture
Firefly luciferase activities of whole cell extracts prepared 48 hrwas incubated at 25C for 10 min, 42C for 50 min, and 95C for 5 min,
posttransfection were normalized with the corresponding -galac-and then rapidly cooled to 4C. cDNA (5 l) was amplified by PCR in
tosidase activities. In all of the assays, the total input DNA/well wasa 20 l reaction mixture containing 1 M (HPRT) or 0.1 M (Deltex1)
kept constant by addition of appropriate amounts of empty controloligonucleotide primers, 0.1 mM dNTPs, 0.1 mg/ml BSA, PCR buffer
plasmids.I (Perkin Elmer), 2.5 mM MgCl2, and 0.5 U Amplitaq DNA Polymerase
(Perkin Elmer). The murine Deltex1 primer pair (5-CACTGGCCCTG
Western BlottingTCCACCCAGCCTTGGCAGG-3 and 5-GGGAAGGCGGGCAACT
293 cells were transfected with empty pcDNA3 plasmid, pcDNA3-CAGGCCTCAGG-3), murine Notch1 primer pair (5-CGGTGTGAGG
ICN1myc, or pcDNA-Deltex1myc, alone or in combination, and 10GTGATGTCAATG -3 and 5-GAATGTCCGGGCCAGCGCCACC-3),
ng of pRL-TK reporter plasmid using Lipofectamine Plus (In-and HPRT control primer pair (5-CACAGGACTAGAACACCTGC-3
vitrogen). Both expression plasmids encoded forms of ICN1 or Del-and 5-GCTGGTGAAAAGGACCTCT-3) all span intron/exon bound-
tex1 with three iterated myc epitope tags at their C termini, permit-aries and give rise to 910 bp, 535 bp, and 249 bp products, respec-
ting their relative levels in extracts to be compared by staining withtively. After a 5 min incubation at 94C, amplification was performed
anti-myc. At 44–48 hr posttransfection, whole cell extracts werefor 35 cycles using the following parameters: 94C (1 min), 68C (1
prepared with 1% NP-40 and normalized for transfection efficiencymin), and 72C (1 min) for Deltex1; 94C (30 s), 66C (30 s), and 72C
based on Renilla luciferase activity as described previously (Aster(30 s) for Notch1, and 94C (30 s), 62C (30 s), and 72C (30 s) for
et al., 2000). After SDS-PAGE and electrophoretic transfer to nitro-HPRT. After a final extension step (72C for 10 min), 5 l of each
cellulose, Western blots were stained with monoclonal myc epitopePCR was analyzed by electrophoresis in a 1.5% agarose gel. The
antibody (clone 9E10), followed by anti-mouse antibody linked toDeltex1 PCR products were transferred to a nylon membrane
horseradish peroxidase (DAKO). Bound antibodies were detectedand hybridized to an end-32P-labeled internal Deltex1-specific oligo-
with the Pierce Supersignal Kit.nucleotide (5-AAGGATGGCAGCCTGCAGTGTCCA-3) at 58C for 2
hr. The membrane was washed in 2 SSC/0.05% SDS once at 25C
Acknowledgmentsand three times at 58C (5 min/wash), exposed to a phosphor screen
for 15 min, and scanned in a PhosporImager.
We thank Gary Koretzky, Craig Thompson, and members of the
Pear and Aster Labs for helpful comments and critical reading of theMurine Bone Marrow Transplantation
manuscript. We thank the members of the University of PennsylvaniaAll experiments were conducted in accordance with National Insti-
John Morgan (Institute for Human Gene Therapy) mouse and flowtutes of Health guidelines for the care and use of animals and with
cytometry facilities. We thank John Choi for the E47 cDNA and E2Aan approved animal protocol from the University of Pennsylvania
reporter and Spyros Artavanis-Tsakonas for the deltex1 cDNA. TheAnimal Care and Use Committee. Young C57Bl/6 (B6) mice were
flow cytometry studies were performed in the University of Pennsyl-obtained from Taconic Farms. Transduction of B6 BM cells with
vania Cancer Center Flow Cytometry and Cell Sorting Shared Re-normalized retroviral supernatants and transplantation of these cells
source (supported in part by the Lucille B. Markey Trust and theinto lethally irradiated (900R) 4- to 8-week-old female syngeneic
National Institutes of Health). This work was supported by grantsrecipients were performed as described (Pui et al., 1999; Aster et
from the National Institutes of Health to J.C.A. and W.S.P. W.S.P.al., 2000). Recipients were sacrificed at the indicated time point,
is a Scholar of the Leukemia and Lymphoma Society.and single-cell suspensions were prepared from peripheral blood.
Received May 22, 2001; revised December 7, 2001.
Fetal Thymic Organ Culture
Reconstitution of fetal thymic lobes with fetal liver hematopoietic References
progenitors was performed ex vivo as described previously (Jenkin-
son et al., 1982; Izon et al., 2001a). Briefly, d15 fetal liver cells (B6) Allman, D., Li, J., and Hardy, R.R. (1999). Commitment to the B
were spun on a Ficoll gradient at 1100  g for 10 min at 25C. lymphoid lineage occurs before DH-JH recombination. J. Exp. Med.
Interface cells were washed once in PBS and resuspended at 1  189, 735–740.
106 cells/ml in 2 ml of Iscove Modified Dulbecco’s media containing
Aravind, L. (2001). The WWE domain: a common interaction module10% FCS, 2 mM glutamine, 0.5 mM penicillin/streptomycin, 50 ng/
in protein ubiquitination and ADP ribosylation. Trends Biochem. Sci.ml SCF, 6 ng/ml IL-3, 4 ng/ml IL-1, and 1 ng/ml IFN-. The next
26, 273–275.day, fetal liver cells were resuspended in 50% (v/v) retroviral super-
Artavanis-Tsakonas, S., Matsuno, K., and Fortini, M.E. (1995). Notchnatant and the above cytokine mixture, spun at 1100  g for 50 min
signaling. Science 268, 225–232.at 25C, and incubated overnight at 37C. The following day, 5 
104 fetal liver cells were washed and placed in hanging drops (30 Artavanis-Tsakonas, S., Rand, M.D., and Lake, R.J. (1999). Notch
signaling: cell fate control and signal integration in development.l) in Terasaki wells containing individual irradiated (2700 Rad) d15
fetal thymic lobes that were harvested from syngeneic fetuses. After Science 284, 770–776.
Immunity
242
Aster, J.C., and Pear, W.S. (2001). Notch signaling in leukemia. Curr. encodes a member of the CDC4 family of proteins. Genes Dev. 11,
3182–3193.Opin. Hematol. 8, 237–244.
Aster, J.C., Xu, L., Karnell, F.G., Patriub, V., Pui, J.C., and Pear, Izon, D.J., Punt, J.A., Xu, L., Karnell, F.G., Allman, D., Myung, P.S.,
Boerth, N.J., Pui, J.C., Koretzky, G.A., and Pear, W.S. (2001a).W.S. (2000). Essential roles for ankyrin repeat and transactivation
domains in induction of T-cell leukemia by Notch1. Mol. Cell. Biol. Notch1 regulates maturation of CD4 and CD8 thymocytes by
modulating TCR signal strength. Immunity 14, 253–264.20, 7505–7515.
Axelrod, J.D., Matsuno, K., Artavanis-Tsakonas, S., and Perrimon, N. Izon, D.J., Rudd, K., DeMuth, W., Pear, W.S., Clendenin, C., Lindsley,
R.C., and Allman, D. (2001b). A common pathway for dendritic cell(1996). Interaction between wingless and Notch signaling pathways
mediated by dishevelled. Science 271, 1826–1832. and early B cell development. J. Immunol. 167, 1387–1392.
Izon, D.J., Punt, J.A., and Pear, W.S. (2002). Deciphering the role ofBain, G., Maandag, E.C., Izon, D.J., Amsen, D., Kruisbeek, A.M.,
Weintraub, B.C., Krop, I., Schlissel, M.S., Feeney, A.J., van Roon, Notch signaling in lymphopoiesis, Curr. Opin. Immunol., in press.
M., et al. (1994). E2A proteins are required for proper B cell develop- Jackson, P.K., Eldridge, A.G., Freed, E., Furstenthal, L., Hsu, J.Y.,
ment and initiation of immunoglobulin gene rearrangements. Cell Kaiser, B.K., and Reimann, J.D. (2000). The lore of the RINGs: sub-
79, 885–892. strate recognition and catalysis by ubiquitin ligases. Trends Cell
Biol. 10, 429–439.Bain, G., Robanus Maandag, E.C., te Riele, H.P., Feeney, A.J.,
Sheehy, A., Schlissel, M., Shinton, S.A., Hardy, R.R., and Murre, C. Jarriault, S., Brou, C., Logeat, F., Schroeter, E.H., Kopan, R., and
(1997). Both E12 and E47 allow commitment to the B cell lineage. Israel, A. (1995). Signalling downstream of activated mammalian
Immunity 6, 145–154. Notch. Nature 377, 355–358.
Bruckner, K., Perez, L., Clausen, H., and Cohen, S. (2000). Glycosyl- Jenkinson, E.J., Franchi, L.L., Kingston, R., and Owen, J.J. (1982).
transferase activity of Fringe modulates Notch-Delta interactions. Effect of deoxyguanosine on lymphopoiesis in the developing thy-
Nature 406, 411–415. mus rudiment in vitro: application in the production of chimeric
thymus rudiments. Eur. J. Immunol. 12, 583–587.Busseau, I., Diederich, R.J., Xu, T., and Artavanis-Tsakonas, S.
(1994). A member of the Notch group of interacting loci, deltex Kao, H.Y., Ordentlich, P., Koyano-Nakagawa, N., Tang, Z., Downes,
encodes a cytoplasmic basic protein. Genetics 136, 585–596. M., Kintner, C.R., Evans, R.M., and Kadesch, T. (1998). A histone
deacetylase corepressor complex regulates the Notch signal trans-Carter, R.S., Ordentlich, P., and Kadesch, T. (1997). Selective utiliza-
tion of basic helix-loop-helix-leucine zipper proteins at the immuno- duction pathway. Genes Dev. 12, 2269–2277.
globulin heavy-chain enhancer. Mol. Cell. Biol. 17, 18–23. Kishi, N., Tang, Z., Maeda, Y., Hirai, A., Mo, R., Ito, M., Suzuki, S.,
Nakao, K., Kinoshita, T., Kadesch, T., et al. (2001). Murine homologsDeftos, M.L., He, Y.W., Ojala, E.W., and Bevan, M.J. (1998). Correlat-
ing notch signaling with thymocyte maturation. Immunity 9, 777–786. of deltex define a novel gene family involved in vertebrate Notch
signaling and neurogenesis. Int. J. Dev. Neurosci. 19, 21–35.Deftos, M.L., Huang, E., Ojala, E.W., Forbush, K.A., and Bevan, M.J.
(2000). Notch1 signaling promotes the maturation of CD4 and CD8 Koch, U., Lacombe, T.A., Holland, D., Bowman, J.L., Cohen, B.L.,
Egan, S.E., and Guidos, C.J. (2001). Subversion of the T/B lineageSP thymocytes. Immunity 13, 73–84.
decision in the thymus by lunatic fringe-mediated inhibition ofDiederich, R.J., Matsuno, K., Hing, H., and Artavanis-Tsakonas, S.
Notch-1. Immunity 15, 225–236.(1994). Cytosolic interaction between deltex and Notch ankyrin re-
peats implicates deltex in the Notch signaling pathway. Develop- Kondo, M., Weissman, I.L., and Akashi, K. (1997). Identification of
clonogenic common lymphoid progenitors in mouse bone marrow.ment 120, 473–481.
Cell 91, 661–672.Ellisen, L.W., Bird, J., West, D.C., Soreng, A.L., Reynolds, T.C.,
Smith, S.D., and Sklar, J. (1991). TAN-1, the human homolog of the Kurooka, H., Kuroda, K., and Honjo, T. (1998). Roles of the ankyrin
repeats and C-terminal region of the mouse notch1 intracellularDrosophila notch gene, is broken by chromosomal translocations
in T lymphoblastic neoplasms. Cell 66, 649–661. region. Nuclic Acids Res. 26, 5448–5455.
Levelt, C.N., and Eichmann, K. (1995). Receptors and signals in earlyGodfrey, D.I., Kennedy, J., Mombaerts, P., Tonegawa, S., and Zlot-
nik, A. (1994). Onset of TCR-beta gene rearrangement and role of thymic selection. Immunity 3, 667–672.
TCR-beta expression during CD3CD4CD8 thymocyte differenti- Li, Y.S., Wasserman, R., Hayakawa, K., and Hardy, R.R. (1996). Iden-
ation. J. Immunol. 152, 4783–4792. tification of the earliest B lineage stage in mouse bone marrow.
Immunity 5, 527–535.Gorman, M.J., and Girton, J.R. (1992). A genetic analysis of deltex
and its interaction with the Notch locus in Drosophila melanogaster. Luo, B., Aster, J.C., Hasserjian, R.P., Kuo, F., and Sklar, J. (1997).
Genetics 131, 99–112. Isolation and functional analysis of a cDNA for human Jagged2, a
gene encoding a ligand for the Notch1 receptor. Mol. Cell. Biol. 17,Greenwald, I. (1998). LIN-12/Notch signaling: lessons from worms
and flies. Genes Dev. 12, 1751–1762. 6057–6067.
Matsuno, K., Diederich, R.J., Go, M.J., Blaumueller, C.M., and Arta-Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D., and Haya-
kawa, K. (1991). Resolution and characterization of pro-B and pre- vanis-Tsakonas, S. (1995). Deltex acts as a positive regulator of
Notch signaling through interactions with the Notch ankyrin repeats.pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173,
1213–1225. Development 121, 2633–2644.
Matsuno, K., Eastman, D., Mitsiades, T., Quinn, A.M., Carcanciu,Hasserjian, R.P., Aster, J.C., Davi, F., Weinberg, D.S., and Sklar, J.
(1996). Modulated expression of notch1 during thymocyte develop- M.L., Ordentlich, P., Kadesch, T., and Artavanis-Tsakonas, S. (1998).
Human deltex is a conserved regulator of Notch signalling. Nat.ment. Blood 88, 970–976.
Genet. 19, 74–78.Hsieh, J.J., Henkel, T., Salmon, P., Robey, E., Peterson, M.G., and
Hayward, S.D. (1996). Truncated mammalian Notch1 activates Moloney, D.J., Panin, V.M., Johnston, S.H., Chen, J., Shao, L., Wil-
son, R., Wang, Y., Stanley, P., Irvine, K.D., Haltiwanger, R.S., andCBF1/RBPJ-repressed genes by a mechanism resembling that of
Epstein-Barr virus EBNA2. Mol. Cell. Biol. 16, 952–959. Vogt, T.F. (2000). Fringe is a glycosyltransferase that modifies Notch.
Nature 406, 369–375.Hsieh, J.J., Nofziger, D.E., Weinmaster, G., and Hayward, S.D. (1997).
Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and Mumm, J.S., and Kopan, R. (2000). Notch signaling: from the outside
in. Dev. Biol. 228, 151–165.blocks differentiation. J. Virol. 71, 1938–1945.
Hsieh, J.J., Zhou, S., Chen, L., Young, D.B., and Hayward, S.D. Ordentlich, P., Lin, A., Shen, C.P., Blaumueller, C., Matsuno, K.,
Artavanis-Tsakonas, S., and Kadesch, T. (1998). Notch inhibition of(1999). CIR, a corepressor linking the DNA binding factor CBF1 to
the histone deacetylase complex. Proc. Natl. Acad. Sci. USA 96, E47 supports the existence of a novel signaling pathway. Mol. Cell.
Biol. 18, 2230–2239.23–28.
Hubbard, E.J., Wu, G., Kitajewski, J., and Greenwald, I. (1997). sel- Pear, W.S., Aster, J.C., Scott, M.L., Hasserjian, R.P., Soffer, B., Sklar,
J., and Baltimore, D. (1996). Exclusive development of T cell neo-10, a negative regulator of lin-12 activity in Caenorhabditis elegans,
Deltex1 in Lymphoid Commitment
243
plasms in mice transplanted with bone marrow expressing activated
Notch alleles. J. Exp. Med. 183, 2283–2291.
Petcherski, A.G., and Kimble, J. (2000). LAG-3 is a putative transcrip-
tional activator in the C. elegans Notch pathway. Nature 405,
364–368.
Pui, J.C., Allman, D., Xu, L., DeRocco, S., Karnell, F.G., Bakkour, S.,
Lee, J.Y., Kadesch, T., Hardy, R.R., Aster, J.C., and Pear, W.S. (1999).
Notch1 expression in early lymphopoiesis influences B versus T
lineage determination. Immunity 11, 299–308.
Radtke, F., Wilson, A., Stark, G., Bauer, M., van Meerwijk, J., Mac-
Donald, H.R., and Aguet, M. (1999). Deficient T cell fate specification
in mice with an induced inactivation of Notch1. Immunity 10,
547–558.
Radtke, F., Ferrero, I., Wilson, A., Lees, R., Aguet, M., and MacDon-
ald, H.R. (2000). Notch1 deficiency dissociates the intrathymic de-
velopment of dendritic cells and T cells. J. Exp. Med. 191, 1085–
1094.
Royet, J., Bouwmeester, T., and Cohen, S.M. (1998). Notchless en-
codes a novel WD40-repeat-containing protein that modulates
Notch signaling activity. EMBO J. 17, 7351–7360.
Sestan, N., Artavanis-Tsakonas, S., and Rakic, P. (1999). Contact-
dependent inhibition of cortical neurite growth mediated by notch
signaling. Science 286, 741–746.
Shawber, C., Nofziger, D., Hsieh, J.J., Lindsell, C., Bogler, O., Hay-
ward, D., and Weinmaster, G. (1996). Notch signaling inhibits muscle
cell differentiation through a CBF1-independent pathway. Develop-
ment 122, 3765–3773.
Wakamatsu, Y., Maynard, T.M., Jones, S.U., and Weston, J.A. (1999).
NUMB localizes in the basal cortex of mitotic avian neuroepithelial
cells and modulates neuronal differentiation by binding to NOTCH-1.
Neuron 23, 71–81.
Wolfer, A., Bakker, T., Wilson, A., Nicolas, M., Ioannidis, V., Littman,
D.R., Wilson, C.B., Held, W., MacDonald, H.R., and Radtke, F. (2001).
Inactivation of Notch 1 in immature thymocytes does not perturb
CD4 or CD8 T cell development. Nat. Immunol. 2, 235–241.
Wu, L., Aster, J.C., Blacklow, S.C., Lake, R., Artavanis-Tsakonas, S.,
and Griffin, J.D. (2000). MAML1, a human homologue of Drosophila
mastermind, is a transcriptional co-activator for NOTCH receptors.
Nat. Genet. 26, 484–489.
Xu, T., and Artavanis-Tsakonas, S. (1990). Deltex, a locus interacting
with the neurogenic genes, Notch, Delta and mastermind in Dro-
sophila melanogaster. Genetics 126, 665–677.
Zhou, S., Fujimuro, M., Hsieh, J.J., Chen, L., Miyamoto, A., Weinmas-
ter, G., and Hayward, S.D. (2000). SKIP, a CBF1-associated protein,
interacts with the ankyrin repeat domain of NotchIC to facilitate
NotchIC function. Mol. Cell. Biol. 20, 2400–2410.
